Clinical Efficacy of a Salicylic Acid–Containing Gel on Acne Management and Skin Barrier Function: A 21‐Day Prospective Study
Journal of Cosmetic Dermatology · 2025-07 · 24 (7)
DOI: 10.1111/jocd.70353 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 19.07.2025. Verfasst von Ye Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital Affiliated to Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Acne Vulgaris, Salicylic Acid. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acne vulgaris is a common skin condition characterized by excessive sebum production, inflammation, and compromised skin barrier function. Effective treatments should target both lesion reduction and skin hydration while maintaining tolerability.
Objective
This study aimed to evaluate the efficacy and tolerability of a salicylic acid–containing gel in reducing sebum levels, improving skin hydration, strengthening the skin barrier, and alleviating acne severity over 21 days.
Methods
A single‐center, prospective clinical trial was conducted on 42 participants (37 females, 5 males, mean age: 25.86 ± 6.69 years) with mild‐to‐moderate acne (IGA grade 2–3) and oily or combination skin. Participants applied the gel twice daily for 21 days. Sebum levels (Sebumeter SM815), trans‐epidermal water loss (TEWL, Tewameter TM Hex), and skin hydration (Corneometer CM825) were measured at multiple time points. Acne severity was assessed using the IGA scale, and self‐reported satisfaction surveys were collected.
Results
Following the follow‐up period, sebum levels decreased by 23.65% ( p < 0.05), while skin hydration increased by 40.5% ( p < 0.05). TEWL decreased by 49.26% ( p < 0.05), indicating enhanced skin barrier function. The IGA score improved by 23.81% ( p < 0.001), demonstrating a significant reduction in acne severity. All participants (100%) reported satisfaction with the product, with notable improvements in oil control, acne reduction, and skin texture. The gel was well tolerated, with only 5% of participants reporting mild, transient itching, which resolved without intervention.
Conclusion
The salicylic acid–containing gel effectively reduces acne lesions, regulates sebum production, enhances skin hydration, and strengthens the skin barrier, making it a suitable option for acne‐prone and sensitive skin. These findings suggest that the gel provides a well‐balanced approach to acne treatment by addressing both clinical efficacy and user comfort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
- L'Oréal Dermatological Beauty China, CeraVe, Shanghai, China.
- L'Oréal China Research and Innovation Center, Shanghai, China.
ORCID-Profile: Yijie Zheng
Zitieren
APA
Liu, Y., Dan, Y., Yang, J., He, X., Liu, J., Yi, Y., Chen, X., Yin, X., Song, W., Niu, Y., Zheng, Y., & Ai, Y. (2025). Clinical Efficacy of a Salicylic Acid–Containing Gel on Acne Management and Skin Barrier Function: A 21‐Day Prospective Study. Journal of Cosmetic Dermatology, 24(7). https://doi.org/10.1111/jocd.70353
Vancouver
Liu Y, Dan Y, Yang J, He X, Liu J, Yi Y, et al. Clinical Efficacy of a Salicylic Acid–Containing Gel on Acne Management and Skin Barrier Function: A 21‐Day Prospective Study. Journal of Cosmetic Dermatology. 2025;24(7). doi:10.1111/jocd.70353
BibTeX
@article{Liu2025,
author = {Liu, Ye and Dan, Yanjun and Yang, Jiahong and He, Xiaofeng and Liu, Jingjing and Yi, Yi and Chen, Xing and Yin, Xue and Song, Weina and Niu, Yueiqng and Zheng, Yijie and Ai, Yunfei},
title = {Clinical Efficacy of a Salicylic Acid–Containing Gel on Acne Management and Skin Barrier Function: A 21‐Day Prospective Study},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {7},
doi = {10.1111/jocd.70353}
}
EUVIMED